KLK3 and prostate cancer: One such context is discriminating between prostate cancer (PC) and benign prostatic hyperplasia (BPH), which may not be reliably accomplished using the measurement of serum prostate-specific antigen (PSA), resulting in many unnecessary biopsies [36].